🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

💡 Scott Bratman (Scott Bratman) shared clinical insights on using ctDNA for MRD detection, extending its applications to early cancer detection and pinpointing tissue of origin. 🧬💉 Another powerful example of how liquid biopsy is redefining the future of early cancer

As part of our PPIE Flash Talks, Alice Groves speaks about the #ACED Cohort study & shows that PPI and continued participant feedback has resulted in improved retention, engagement, and recruitment of participants. So, basically: 📈more data 🥼more samples 💻wider usability of

📚"We need to rewrite the playbook for evaluation of cancer screening tech", says Ruth Etzioni of Fred Hutch Cancer Center in our panel discussion about the future of evaluation of cancer screening technologies. #EDxConf24 | Tom Beer | Exact Sciences | UVA | Hilary Robbins | IARC |

💡 Tiffani Howard emphasized the critical role of community engagement in patient recruitment during clinical trials. “The message matters” underscores the importance of involving patient advocates and community advisory boards to ensure meaningful diversity and representation.

💡 Kate Brain highlighted key barriers to inclusion in clinical trials: accessibility and acceptability. Her message? We must value people as individuals and ensure diverse voices are included at every step of study design. 🌍🌏🌎🤝 #ClinicalTrials #InclusionMatters

💡 Rhian Gabe presented the TRANSFORM prostate cancer trial, addressing the balance between PSA screening benefits and the ongoing concern of overdiagnosis in the EU & UK. She emphasized that evolving MRI practices and integrating new technologies with risk stratification could

The 2024 Don Listwin Award for Outstanding Contribution to Cancer Early Detection winner is Antonis Antoniou, PhD. Congratulations, Dr. Antoniou! earlydetectionresearch.com #EDxConf24 OHSU Knight Cancer Institute Science and Innovation at Cancer Research UK

💬⚔️ Great Debate Recap: "Is research on early detection of rare cancers a waste of money?" Moderated by David Crosby (Science and Innovation at Cancer Research UK) FOR: Paul Spellman (UCLA) argued that focusing on common cancers, responsible for 2/3 of deaths, has the greatest impact. He highlighted the

🌆 Day 2 wrapped up with a thrilling finale! Professor Antonis Antoniou (Antonis Antoniou | Cambridge University) was honored with this year’s prestigious Don Listwin Award 🏆🎉 We hope everyone enjoyed the evening celebrations! 🥂✨ #DonListwinAward #CancerResearch #CelebratingExcellence

🚀🚀🚀 The final day of #EDxConf24 is about to kick off—let’s finish strong! 💪 Still Prima (Prima Dewi Sinawang) reporting. Check out the agenda 👉 earlydetectionresearch.com It’s not goodbye yet, but huge thanks to our amazing sponsors and partners for making this event happen! 🙌

💡 Bissan Al-Lazikani (@bissanao) kicked off our AI session with an introduction to foundation models! 🤖 Her focus? Harnessing signal propagation and cooperativity to uncover key cancer features. With the power of multimodal data, she emphasized the potential of predictive

💡 Jens Rittscher (Jens Rittscher) is leveraging AI to analyze endoscopy images for Barrett’s esophagus. 🤖🔬 His lab focuses on automated quantification for data-driven phenotyping, with exciting potential to extend into spatial transcriptomics and thicker tissue

💡Su-In Lee (Su-In Lee), pioneer in explainable AI (XAI), explained the importance of “prediction with explanation.” 🤖 She shared her lab’s work using XAI to: 🔹 Select optimal combination therapies 🔹 Understand drug synergy and hematopoietic “stemness” 🔹 Build on

💡 Sylvia Plevritis (Stanford Plevritis Lab | Stanford Medicine) and Cathie Sudlow (Health Data Research UK (HDR UK)) led today’s AI discussion session with @bissanao, Jens Rittscher, and Su-In Lee. 👉The discussion emphasized that predictive models are powerful, but AI must be treated like any diagnostic tool.

💡 Azra Raza (Azra Raza) delivered a powerful talk on her mission to prevent and cure cancer effectively. Drawing from her book The First Cell, she emphasized the importance of identifying stress biomarkers that trigger cancer—shifting the focus from treating advanced disease

🎉 That’s a wrap, folks! #EDxConf2024 may have come to an end, but our mission to revolutionize cancer early detection continues stronger than ever. 🚀 We are beyond grateful to all the speakers, attendees, sponsors, and partners who made this event unforgettable. Your ideas,